Form 8-K - Current report:
SEC Accession No. 0001558370-25-008627
Filing Date
2025-06-13
Accepted
2025-06-13 17:27:13
Documents
13
Period of Report
2025-06-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K qure-20250611x8k.htm   iXBRL 8-K 91381
2 EX-10.1 qure-20250611xex10d1.htm EX-10.1 91490
  Complete submission text file 0001558370-25-008627.txt   315337

Data Files

Seq Description Document Type Size
3 EX-101.SCH qure-20250611.xsd EX-101.SCH 3457
4 EX-101.LAB qure-20250611_lab.xml EX-101.LAB 15217
5 EX-101.PRE qure-20250611_pre.xml EX-101.PRE 9967
15 EXTRACTED XBRL INSTANCE DOCUMENT qure-20250611x8k_htm.xml XML 4645
Mailing Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP
Business Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP 1-339-970-7000
uniQure N.V. (Filer) CIK: 0001590560 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36294 | Film No.: 251047783
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)